NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,033 | -47.0% | 61,713 | +28.2% | 0.00% | – |
| Q2 2023 | $124,703 | -67.5% | 48,148 | -48.8% | 0.00% | – |
| Q1 2023 | $383,568 | +64.7% | 94,012 | +102.6% | 0.00% | – |
| Q4 2022 | $232,903 | -99.6% | 46,395 | -98.9% | 0.00% | -100.0% |
| Q3 2022 | $56,560,000 | +114.1% | 4,324,201 | +109.9% | 0.01% | +100.0% |
| Q2 2022 | $26,416,000 | +36.0% | 2,060,533 | +61.8% | 0.00% | +50.0% |
| Q1 2022 | $19,417,000 | -15.7% | 1,273,186 | -2.1% | 0.00% | 0.0% |
| Q4 2021 | $23,043,000 | -16.2% | 1,301,138 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $27,493,000 | +588.7% | 1,307,937 | +353.8% | 0.00% | – |
| Q3 2019 | $3,992,000 | -5.4% | 288,200 | 0.0% | 0.00% | – |
| Q2 2019 | $4,219,000 | – | 288,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |